• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

胱氨酸尿症和高尿酸尿相关钙结石的潜在药物治疗方法。

Potential pharmacologic treatments for cystinuria and for calcium stones associated with hyperuricosuria.

机构信息

Nephrology Section/111G, NY DVAMC, 423 E. 23 Street, New York, NY 10010, USA.

出版信息

Clin J Am Soc Nephrol. 2011 Aug;6(8):2093-7. doi: 10.2215/CJN.00320111. Epub 2011 Jul 14.

DOI:10.2215/CJN.00320111
PMID:21757641
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC3156434/
Abstract

Two new potential pharmacologic therapies for recurrent stone disease are described. The role of hyperuricosuria in promoting calcium stones is controversial with only some but not all epidemiologic studies demonstrating associations between increasing urinary uric acid excretion and calcium stone disease. The relationship is supported by the ability of uric acid to "salt out" (or reduce the solubility of) calcium oxalate in vitro. A randomized, controlled trial of allopurinol in patients with hyperuricosuria and normocalciuria was also effective in preventing recurrent stones. Febuxostat, a nonpurine inhibitor of xanthine oxidase (also known as xanthine dehydrogenase or xanthine oxidoreductase) may have advantages over allopurinol and is being tested in a similar protocol, with the eventual goal of determining whether urate-lowering therapy prevents recurrent calcium stones. Treatments for cystinuria have advanced little in the past 30 years. Atomic force microscopy has been used recently to demonstrate that effective inhibition of cystine crystal growth is accomplished at low concentrations of l-cystine methyl ester and l-cystine dimethyl ester, structural analogs of cystine that provide steric inhibition of crystal growth. In vitro, l-cystine dimethyl ester had a significant inhibitory effect on crystal growth. The drug's safety and effectiveness will be tested in an Slc3a1 knockout mouse that serves as an animal model of cystinuria.

摘要

描述了两种新的潜在的用于复发性结石病的药物治疗方法。高尿酸尿症在促进钙结石形成中的作用存在争议,只有部分而不是所有的流行病学研究表明尿尿酸排泄增加与钙结石病之间存在关联。尿酸能够“盐析”(或降低)体外草酸钙的溶解度,这支持了这种关联。一项在高尿酸尿和正常钙尿患者中进行的别嘌醇随机对照试验也有效地预防了复发性结石。黄嘌呤氧化酶(也称为黄嘌呤脱氢酶或黄嘌呤氧化还原酶)的非嘌呤抑制剂非布司他可能比别嘌醇更有优势,并且正在按照类似的方案进行测试,最终目的是确定尿酸降低疗法是否可以预防复发性钙结石。胱氨酸尿症的治疗在过去 30 年中几乎没有进展。最近,原子力显微镜已被用于证明,低浓度的 l-胱氨酸甲酯和 l-胱氨酸二甲基酯可有效抑制胱氨酸晶体生长,这两种结构类似物可提供晶体生长的空间位阻抑制。在体外,l-胱氨酸二甲基酯对晶体生长有显著的抑制作用。该药物的安全性和有效性将在 Slc3a1 敲除小鼠中进行测试,Slc3a1 敲除小鼠是胱氨酸尿症的动物模型。

相似文献

1
Potential pharmacologic treatments for cystinuria and for calcium stones associated with hyperuricosuria.胱氨酸尿症和高尿酸尿相关钙结石的潜在药物治疗方法。
Clin J Am Soc Nephrol. 2011 Aug;6(8):2093-7. doi: 10.2215/CJN.00320111. Epub 2011 Jul 14.
2
Treatment of calcium nephrolithiasis in the patient with hyperuricosuria.高尿酸尿症患者的钙肾结石治疗
J Nephrol. 2014 Dec;27(6):601-5. doi: 10.1007/s40620-014-0084-x. Epub 2014 Apr 1.
3
Randomized controlled trial of febuxostat versus allopurinol or placebo in individuals with higher urinary uric acid excretion and calcium stones.随机对照试验:非布司他对比别嘌醇或安慰剂治疗高尿酸尿症合并钙结石患者
Clin J Am Soc Nephrol. 2013 Nov;8(11):1960-7. doi: 10.2215/CJN.01760213. Epub 2013 Aug 8.
4
Disrupting Crystal Growth through Molecular Recognition: Designer Therapies for Kidney Stone Prevention.通过分子识别破坏晶体生长:用于预防肾结石的设计疗法。
Acc Chem Res. 2022 Feb 15;55(4):516-525. doi: 10.1021/acs.accounts.1c00631. Epub 2022 Jan 28.
5
Cystinuria: genetic aspects, mouse models, and a new approach to therapy.胱氨酸尿症:遗传方面、小鼠模型和一种新的治疗方法。
Urolithiasis. 2019 Feb;47(1):57-66. doi: 10.1007/s00240-018-1101-7. Epub 2018 Dec 4.
6
[Pathophysiology, diagnosis and conservative therapy of non-calcium kidney calculi].[非钙性肾结石的病理生理学、诊断及保守治疗]
Ther Umsch. 2003 Feb;60(2):89-97. doi: 10.1024/0040-5930.60.2.89.
7
Idiopathic recurrent calcium urolithiasis (IRCU): variation of fasting urinary protein is a window to pathophysiology or simple consequence of renal stones in situ? A tripartite study in male patients providing insight into oxidative metabolism as possible driving force towards alteration of urine composition, calcium salt crystallization and stone formation.特发性复发性钙尿路结石(IRCU):空腹尿蛋白的变化是病理生理学的窗口,还是肾结石原位的简单结果?一项针对男性患者的三方研究,深入探讨氧化代谢作为尿液成分改变、钙盐结晶和结石形成的可能驱动力。
Eur J Med Res. 2009 Sep 1;14(9):378-92. doi: 10.1186/2047-783x-14-9-378.
8
Dietary treatment of urinary risk factors for renal stone formation. A review of CLU Working Group.肾结石形成的尿液危险因素的饮食治疗。CLU工作组综述
Arch Ital Urol Androl. 2015 Jul 7;87(2):105-20. doi: 10.4081/aiua.2015.2.105.
9
The spectrum of metabolic abnormalities in patients with cystine nephrolithiasis.胱氨酸肾结石患者的代谢异常谱。
J Urol. 1989 Apr;141(4):819-21. doi: 10.1016/s0022-5347(17)41019-6.
10
[Calcium lithiasis: uric acid under question].[钙结石:尿酸存疑]
Nephrologie. 1984;5(5):192-4.

引用本文的文献

1
Novel compound heterozygous pathogenic variants in the SLC3A1 gene in a Chinese family with cystinuria.一个胱氨酸尿症的中国家庭中 SLC3A1 基因的新型复合杂合致病性变异。
BMC Med Genomics. 2023 Dec 19;16(1):333. doi: 10.1186/s12920-023-01767-6.
2
Differences in renal cortex transcriptional profiling of wild-type and novel type B cystinuria model rats.野生型和新型 B 型胱氨酸尿症模型大鼠肾皮质转录谱的差异。
Urolithiasis. 2022 Jun;50(3):279-291. doi: 10.1007/s00240-022-01321-6. Epub 2022 Apr 13.
3
Amino Acid Transport Defects in Human Inherited Metabolic Disorders.氨基酸转运缺陷与人类遗传性代谢紊乱
Int J Mol Sci. 2019 Dec 23;21(1):119. doi: 10.3390/ijms21010119.
4
Cystinuria: genetic aspects, mouse models, and a new approach to therapy.胱氨酸尿症:遗传方面、小鼠模型和一种新的治疗方法。
Urolithiasis. 2019 Feb;47(1):57-66. doi: 10.1007/s00240-018-1101-7. Epub 2018 Dec 4.
5
Safety and Efficacy of Benzbromarone and Febuxostat in Hyperuricemia Patients with Chronic Kidney Disease: A Prospective Pilot Study.苯溴马隆和非布司他在慢性肾脏病高尿酸血症患者中的安全性和有效性:一项前瞻性试点研究。
Clin Exp Nephrol. 2018 Dec;22(6):1324-1330. doi: 10.1007/s10157-018-1586-y. Epub 2018 May 14.
6
Early Recognition and Management of Rare Kidney Stone Disorders.罕见肾结石疾病的早期识别与管理
Urol Nurs. 2017 Mar-Apr;37(2):81-9, 102.
7
ACVIM Small Animal Consensus Recommendations on the Treatment and Prevention of Uroliths in Dogs and Cats.美国兽医内科学会关于犬猫尿石症治疗与预防的小动物共识推荐
J Vet Intern Med. 2016 Sep;30(5):1564-1574. doi: 10.1111/jvim.14559. Epub 2016 Sep 9.
8
Novel cystine ester mimics for the treatment of cystinuria-induced urolithiasis in a knockout mouse model.用于治疗基因敲除小鼠模型中胱氨酸尿症诱发的尿路结石的新型胱氨酸酯模拟物。
Urology. 2014 Nov;84(5):1249.e9-15. doi: 10.1016/j.urology.2014.07.043. Epub 2014 Oct 24.
9
Cystinuria-a urologist's perspective.胱氨酸尿症——泌尿科医生的视角。
Nat Rev Urol. 2014 May;11(5):270-7. doi: 10.1038/nrurol.2014.51. Epub 2014 Mar 25.
10
Recent finding and new technologies in nephrolitiasis: a review of the recent literature.肾结石研究的新发现和新技术:对近期文献的综述。
BMC Urol. 2013 Feb 16;13:10. doi: 10.1186/1471-2490-13-10.

本文引用的文献

1
Crystal growth inhibitors for the prevention of L-cystine kidney stones through molecular design.通过分子设计抑制 L-胱氨酸肾结石的晶体生长。
Science. 2010 Oct 15;330(6002):337-341. doi: 10.1126/science.1191968.
2
Pharmacotherapy of urolithiasis: evidence from clinical trials.尿石症的药物治疗:来自临床试验的证据。
Kidney Int. 2011 Feb;79(4):385-92. doi: 10.1038/ki.2010.389. Epub 2010 Oct 6.
3
Pathophysiology and treatment of cystinuria.胱氨酸尿症的病理生理学和治疗。
Nat Rev Nephrol. 2010 Jul;6(7):424-34. doi: 10.1038/nrneph.2010.69. Epub 2010 Jun 1.
4
International position paper on febuxostat.国际别嘌醇立场文件。
Clin Rheumatol. 2010 Aug;29(8):835-40. doi: 10.1007/s10067-010-1457-8. Epub 2010 Apr 17.
5
Hyperuricemia, gout, and cardiovascular disease--an important "muddle".高尿酸血症、痛风与心血管疾病——一个重要的“谜团”。
Bull NYU Hosp Jt Dis. 2009;67(3):285-90.
6
Bladder outlet obstruction in male cystinuria mice.男性胱氨酸尿症小鼠的膀胱出口梗阻。
Int Urol Nephrol. 2010 Mar;42(1):57-63. doi: 10.1007/s11255-009-9597-y. Epub 2009 May 31.
7
Effects of febuxostat versus allopurinol and placebo in reducing serum urate in subjects with hyperuricemia and gout: a 28-week, phase III, randomized, double-blind, parallel-group trial.非布司他与别嘌醇及安慰剂对高尿酸血症和痛风患者降低血清尿酸的作用:一项为期28周的III期随机双盲平行组试验。
Arthritis Rheum. 2008 Nov 15;59(11):1540-8. doi: 10.1002/art.24209.
8
Cystinuria.胱氨酸尿症
Semin Nephrol. 2008 Mar;28(2):181-91. doi: 10.1016/j.semnephrol.2008.01.011.
9
24-h uric acid excretion and the risk of kidney stones.24小时尿酸排泄与肾结石风险
Kidney Int. 2008 Feb;73(4):489-96. doi: 10.1038/sj.ki.5002708. Epub 2007 Dec 5.
10
Atomic force microscopy of the electrochemical nucleation and growth of molecular crystals.原子力显微镜下电化学诱导的分子晶体成核与生长。
Science. 1994 Mar 4;263(5151):1261-4. doi: 10.1126/science.263.5151.1261.